CIT trades at 11.47x book while book value erodes

At Rs 1,748.8, the market is trading Citizen Investment Trust as a scarce, state-anchored franchise rather than as an earnings stream: the price-to-book stands at 11.47, the price-to-earnings at 88.1 and the return on equity at 13.01%. What buyers are paying for is the mandate — the government-sponsored unit trust listed on NEPSE, a franchise no other listed company can replicate. What the price is discounting is that the numbers underneath are good but ordinary, and that the erosion of book value over the last two fiscal years will prove to be a phase rather than a condition.

A premium built on scarcity

CIT carries the highest price-to-book in the Investment sector. The sector's median price-to-book is 5.25; CIT trades at 11.47. The peer set makes the premium visible: CHDC, the one peer with a higher ROE at 22.74%, trades at 8.62 times book and 37.9 times earnings; HIDCL at 2.28 times book and 94.2 times earnings with a 2.42% ROE; NIFRA at 2.15 times book, 55.3 times earnings and a 3.9% ROE; ENL at 4.44 times book and 181.1 times earnings; HATHY at 6.06 times book and a 691.5 multiple on a 0.87% ROE; and NRN at 8.15 times book with a negative ROE. The sector's median ROE is 2.44%. CIT's 13.01% makes it an earnings-quality outlier, yet even against that backdrop the market has priced it ahead of every comparable: at a price-to-earnings of 88.1 the earnings yield is 1.13%, a level that prices the name, not the income. The reason is structural: government sponsorship and the only pure unit-trust mandate on the exchange. The market capitalisation of Rs 119.02 arba is being carried on the franchise's scarcity value. This explains the way the stock behaves more than anything on the income statement: a beta of 0.54, and a price that moved just 0.1% across the last 20 sessions. The market is not paying for CIT to do anything; it is paying for CIT to exist.

A steady, decelerating income line

Revenue has grown in every one of the six fiscal years in view: Rs 1.27 arba in FY 2077/78, then Rs 1.49 arba (+17.7%), Rs 1.81 arba (+21.5%), Rs 1.92 arba (+6.2%), Rs 2.10 arba (+9%) and Rs 2.25 arba (+7.3%) in FY 2082/83. The latest year was carried by the two engines a unit trust has — interest income, up 8.1%, and fees and commission income, up 8.4% — against a 7.3% rise in total revenue. Net profit has compounded from Rs 71.97 crore in FY 2077/78 to Rs 135.03 crore in FY 2082/83, but the pace keeps slowing: up 23.4% in FY 2078/79, 2.3% in FY 2079/80, 21.4% in FY 2080/81, 13.7% in FY 2081/82 and 7.7% last year. The earnings-per-share line is flatter still: Rs 23.76 in FY 2077/78, Rs 27.15 in FY 2078/79, Rs 17.08 in FY 2079/80, Rs 20.75 in FY 2080/81, Rs 19.34 in FY 2081/82 and Rs 19.84 in FY 2082/83. EPS is up a meagre 2.6% on the year even though net profit rose 7.7%, because paid-up capital grew 5%; and EPS remains below the Rs 27.15 earned in FY 2078/79. The market has priced exactly that reality — a share that gained 0.85% across 60 sessions while NEPSE fell 1.65%, and a share that has drifted down 3.03% over 250 sessions. In a sector where the median company earns a 2.44% ROE, a 13.01% ROE is a distinction; but the buyer of CIT at 88.1 times earnings is buying a steady, single-digit-growth income line, not a compounding machine. The price no longer rises when profit rises; it rises only when the franchise story does.

The eroding book

Here is the metric that spoils the story. Book value per share: Rs 146.11 in FY 2077/78, Rs 238.65 in FY 2078/79 (+63.3%), Rs 154.81 in FY 2079/80 (-35.1%), Rs 171.45 in FY 2080/81 (+10.7%), Rs 164.23 in FY 2081/82 (-4.2%) and Rs 152.47 in FY 2082/83 (-7.2%). Two consecutive years of decline. The latest filing shows why the figure keeps slipping while profit rises: total equity is down 2.5% to Rs 10.38 arba; reserve funds are down 14.2%; and paid-up capital is up 5% — so the same profit is spread over more shares. Meanwhile total assets rose 19% to Rs 370.28 arba and investments rose 13.3%. The balance sheet is growing faster than shareholders' funds, and it is growing outside the equity that the stock is priced against: assets of Rs 311.07 arba a year earlier became Rs 370.28 arba, while the equity base fell from Rs 10.65 arba to Rs 10.38 arba. The return on equity has traced 15.06% in FY 2077/78, then 11.38%, 11.04%, 12.10%, 11.78% and 13.01% in FY 2082/83 — a recovery that is real but partly arithmetic, since the equity base is smaller. The trust manages other people's money, and its fee income rose 8.4%; the erosion is in the shareholders' book, not in the franchise. Against all this, the multiple is striking: every rupee of book value is priced at 11.47 times. The market is betting that the franchise can rebuild the book from internal earnings, and the tape shows a patient bet — the stock is 8.58% below its 52-week high of Rs 1,913 and has made no attempt on it in the past year, sitting at Rs 1,748.8. The eroding book is the one line in the financial statements that the 88.1 multiple has not yet priced; if the decline continues, the multiple stands on a base that is shrinking underneath it.

The trading behaviour says the same thing as the multiples, only more plainly. Across 60 sessions to 30 October 2026, CIT is up 0.85% while NEPSE is down 1.65% and the sector median is down 2.46%; across 250 sessions it is down 3.03% while the index is up 2.51% but the sector median is down 4.69%. In both windows the stock has beaten the median of a sector that is barely profitable, and in both windows it has lagged the index's momentum. The 52-week range is Rs 1,621.1 to Rs 1,913, and the last close of Rs 1,748.8 sits 8.58% off the high, near the middle of the band. Turnover is thin and thinning: an average daily turnover of Rs 71.53 lakh over the last 20 sessions against Rs 78.73 lakh over the prior 60, down 9.1%. The latest stretch is the quietest — over 20 sessions the price is up 0.1%, essentially static, absorbing small amounts of turnover near the middle of the band with no push toward either extreme and no expansion of participation. At a beta of 0.54, this is a very low-volatility stock for the sector, and it trades as such: a price that resists the index's pull in both directions and a tape with nothing new being argued.

The read, as a read of trading rather than of value: CIT is being traded as a range-bound, low-beta quasi-sovereign asset. The price is made by scarcity and sponsorship, not by the 1.13% earnings yield nor by the 7.7% profit growth; the market pays 11.47 times book for a book that is 7.2% smaller than a year ago, and it does so quietly — no trend, no volume, no urgency. The read breaks if the price leaves the Rs 1,621.1–1,913 band on a sustained step-up in turnover from the recent lakh-level daily average, in either direction. A break below the low would show the scarcity premium deflating while profit still rises; a break above the high on volume would show the market starting to price the asset base — Rs 370.28 arba — rather than the franchise. And the quietest break of all: a fiscal year in which book value per share stops falling while net profit keeps rising would hand the multiple the foundation it currently lacks.